Search by Drug Name or NDC
NDC 62332-0709-05 Olopatadine Hydrochloride 1 mg/mL Details
Olopatadine Hydrochloride 1 mg/mL
Olopatadine Hydrochloride is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN OTC DRUG category. It is labeled and distributed by Alembic Pharmaceuticals Inc.. The primary component is OLOPATADINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Prescription ophthalmic olopatadine (Pazeo) and nonprescription ophthalmic olopatadine (Pataday) are used to relieve itchy eyes caused by allergic reactions to pollen, ragweed, grass, animal hair, or pet dander. Olopatadine is in a class of medications called mast cell stabilizers. It works by preventing the release of substances that cause eye itching.
Related Packages: 62332-0709-05Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Olopatadine Ophthalmic
Product Information
NDC | 62332-0709 |
---|---|
Product ID | 62332-709_3b330307-f5b5-473f-a4dd-56a080a1b518 |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Olopatadine Hydrochloride |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | olopatadine hydrochloride |
Product Type | HUMAN OTC DRUG |
Dosage Form | SOLUTION/ DROPS |
Route | OPHTHALMIC |
Active Ingredient Strength | 1 |
Active Ingredient Units | mg/mL |
Substance Name | OLOPATADINE HYDROCHLORIDE |
Labeler Name | Alembic Pharmaceuticals Inc. |
Pharmaceutical Class | Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA209919 |
Listing Certified Through | 2024-12-31 |
Package
Package Images


NDC 62332-0709-05 (62332070905)
NDC Package Code | 62332-709-05 |
---|---|
Billing NDC | 62332070905 |
Package | 1 BOTTLE in 1 CARTON (62332-709-05) / 5 mL in 1 BOTTLE |
Marketing Start Date | 2021-02-18 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL bd1f9779-d048-46ff-a570-ce3ad92715e7 Details
DO NOT USE
WHEN USING THIS PRODUCT
STOP USE AND ASK DOCTOR IF
KEEP OUT OF REACH OF CHILDREN
DIRECTIONS
• adults and children 2 years of age and older:
• put 1 drop in the affected eye(s) twice daily, every 6 to 8 hours, no more than twice per day
• if using other ophthalmic products while using this product, wait at least 5 minutes between each product
• replace cap after each use
• children under 2 years of age: consult a doctor
INACTIVE INGREDIENTS
PRINCIPAL DISPLAY PANEL
INGREDIENTS AND APPEARANCE
OLOPATADINE HYDROCHLORIDE
olopatadine hydrochloride solution/ drops |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Labeler - Alembic Pharmaceuticals Inc. (079288842) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Gland Pharma Limited | 918601238 | MANUFACTURE(62332-709) |